You have 9 free searches left this month | for more free features.

Hemosiderosis

Showing 51 - 72 of 72

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Transfusional Iron Overload Trial in Greece, Italy, United States (ICL670)

Completed
  • Transfusional Iron Overload
  • Oakland, California
  • +17 more
Feb 21, 2017

Iron Overload Trial in Leipzig (Deferasirox)

Completed
  • Iron Overload
  • Leipzig, Germany
    Novartis Investigative Site
Nov 16, 2016

The Silent Cortical Infarcts in Cerebral Amyloid Angiopathy: Is

Completed
  • CADASIL
  • No intervention
  • Paris, Ile-de-France, France
    Groupe Hospitalier Paris Saint Joseph
Jul 18, 2016

Children Aged 2 to <6 Years With Transfusional Iron Overload

Completed
  • Anemia
  • Mobile, Alabama
  • +22 more
Dec 26, 2015

Iron Overload Trial in Halifax (monthly phlebotomy x 12 months)

Completed
  • Iron Overload
  • monthly phlebotomy x 12 months
  • Halifax, Nova Scotia, Canada
    QEII Health Sciences Centre
Jan 30, 2017

Bone Status on Genetic Hemochromatosis:3 Years Descriptive and

Completed
  • Genetic Hemochromatosis
    • Angers, France
    • +5 more
    May 26, 2015

    Pharmacogenetic Study in Patients Received Iron Chelating Agent

    Completed
    • Hemosiderosis
      • Seoul, Chongno-gu, Korea, Republic of
        Seoul National University Hospital
      Jul 11, 2014

      New Phenotypic Biological Marker in Genetic Type 1

      Completed
      • Hereditary Hemochromatosis C282Y Homozygous
        • Rennes, France
          CHU
        Jul 23, 2014

        Transfusional Iron Overload, Transfusional Hemosiderosis Trial in Worldwide (Core Study: Deferasirox, Core Study: Deferoxamine,

        Completed
        • Transfusional Iron Overload
        • Transfusional Hemosiderosis
        • Core Study: Deferasirox
        • +5 more
        • Toronto, Ontario, Canada
        • +20 more
        Aug 13, 2014

        Stachybotrys Induced Hemorrhage in the Developing Lung

        Completed
        • Idiopathic Pulmonary Hemorrhage
          • Cleveland, Ohio
            Rainbow Babies and Children's Hospital, Case Western Reserve Uni
          Apr 13, 2015

          Implications for Quality of Life and Quality of Care in

          Unknown status
          • Hereditary Haemochromatosis
          • Interviews, questionaires, RAND-modified delphi method round
          • Leuven, Vlaams-brabant, Belgium
            UZ Leuven
          Nov 18, 2013

          Iron Overload Trial in China (Desferasirox)

          Completed
          • Iron Overload
          • Shanghai, Shanghai, China
          • +6 more
          Oct 27, 2014

          Normal Myocardial T1, T2 and T2* Values Trial in Rouen (Magnetic Resonance Imaging)

          Completed
          • Normal Myocardial T1, T2 and T2* Values
          • Magnetic Resonance Imaging
          • Rouen, France
            Rouen University Hospital
          Sep 5, 2014

          Beta-thalassemia Major, Sickle Cell Disease, Iron Hemosiderosis Trial in Cairo (DFP (ferriprox) and deferasirox (ICL 670), DFP,

          Unknown status
          • Beta-thalassemia Major
          • +2 more
          • DFP (ferriprox) and deferasirox (ICL 670)
          • DFP, DFO
          • Cairo, Egypt
            Pediatric Hematology clinic, Ain Shams University
          Feb 3, 2012

          Beta-Thalassemia Trial in United States (ICL670, deferoxamine)

          Completed
          • Beta-Thalassemia
          • Los Angeles, California
          • +6 more
          Apr 18, 2012

          Hemochromatosis Trial in Leuven, Heerlen, Maastricht (Pantoprazole)

          Unknown status
          • Hemochromatosis
          • Leuven, Limburg, Belgium
          • +2 more
          Feb 1, 2012

          Beta-thalassemia Major, Hemosiderosis, Iron Overload Trial in Worldwide (Deferasirox)

          Completed
          • Beta-thalassemia Major
          • +3 more
          • Cairo, Egypt
          • +4 more
          Aug 28, 2011

          Anemia, Hemosiderosis Trial in Worldwide (Deferasirox)

          Completed
          • Anemia
          • Hemosiderosis
          • Oakland, California
          • +27 more
          Apr 15, 2011

          Hepatic And Myocardial Iron Through T2* Magnet Resonance Imaging

          Completed
          • Hematological Diseases
          • Liver Biopsy and MRI T2* MRI
          • Memphis, Tennessee
            St. Jude Children's Research Hospital
          Sep 14, 2011

          Sickle Cell Disease Trial in Worldwide (ICL670)

          Completed
          • Sickle Cell Disease
          • Mobile, Alabama
          • +38 more
          May 3, 2011

          Iron Deposition in Major Organs of Hemodialysis Patients

          Unknown status
          • Iron Overload
            • Holon, Israel
              Wolfsson Medical Center
            Jul 23, 2010

            Iron Overload in African Americans

            Completed
            • Hemochromatosis
            • Iron Overload
              • Bethesda, Maryland
                National Institute of Child Health and Human Development (NICHD)
              Mar 3, 2008